1. Non-femoral TAVR: Time to stratify alternative vascular approaches
- Author
-
Paul Guedeney and Roxana Mehran
- Subjects
medicine.medical_specialty ,Transcatheter aortic ,medicine.medical_treatment ,Less invasive ,Physician Decision ,030204 cardiovascular system & hematology ,Transcatheter Aortic Valve Replacement ,03 medical and health sciences ,0302 clinical medicine ,Valve replacement ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,In patient ,030212 general & internal medicine ,Prospective Studies ,Prospective cohort study ,Aged ,business.industry ,General Medicine ,Gold standard (test) ,Aortic Valve Stenosis ,United States ,Surgery ,Treatment Outcome ,Aortic Valve ,France ,Cardiology and Cardiovascular Medicine ,business - Abstract
Although transfemoral transcatheter aortic valve replacement (TAVR) is the gold standard, this approach is not be feasible in approximately 15% of the patients. Trans-carotid TAVR may be less invasive than transthoracic routes for TAVR, and has been associated with encouraging results. Further prospective studies comparing alternative access routes in patients with whom transfemoral TAVR is not feasible are warranted, to propose an evidence-based algorithm guiding the physician decision.
- Published
- 2018